Edit |   |
---|---|
Antigenic Specificity | CTLA-4 (Ipilimumab biosimilar) |
Clone | monoclonal |
Host Species | Humanized |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | Protein A/G purified, low endotoxin |
Size | 10mg |
Concentration | 1.0 - 5.0 mg/ml |
Applications | RUO |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Specificity: detects human CTLA-4. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Ipilimumab. Ipilimumab biosimilar is a recombinant, human monoclonal antibody that binds to the cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4). Ipilimumab biosimilar is an IgG1 kappa immunoglobulin with an approximate molecular weight of 148 kDa. Ipilimumab biosimilar is produced in mammalian (Chinese hamster ovary) cell culture. |
Immunogen | n/a |
Other Names | Ctla4, Cytotoxic T-lymphocyte protein 4, CD152 |
Gene, Accession # | UniProt: P16410 |
Catalog # | ICH4025-10mg |
Price | $1145 |
Order / More Info | CTLA-4 (Ipilimumab biosimilar) Antibody from ICHORBIO |
Product Specific References | n/a |
U.S. OFFICE
987 Old Eagle School Rd, Ste 709
Wayne, PA 19087
us@ichor.bio